| Prev Close | 38.27 |
| Day Low/High | 38.16 / 38.62 |
| 52 Wk Low/High | 27.88 / 40.97 |
Pfizer Inc. (PFE)
38.45
NYSE
| Exchange | NYSE |
| Shares Outstanding | 5554.83B |
| Market Cap | 212.58B |
| P/E Ratio | 13.73 |
| Div & Yield | N.A. (N.A) |
Pfizer Looks Poised for a Breakout
Aggressive traders could go long PFE at current levels.
Novice Trade: Pfizer
This is a bullish, long call shooter.
Novice Trade: Pfizer
The trade for highly discretionary capital is the in-the-money, long call shooter expiring in January.
Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers
Blueprint unveiled new data from its ongoing Phase 1 study of avapritinib in advanced systemic mastocytosis at the 59th American Society of Hematology Annual Meeting.
Six Off the Beaten Path Healthcare Stock Gems
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
Novice Trade: Pfizer
This is a bullish, but very risky trade.
On Halloween, Here Are 5 Scary Stock Charts: Market Recon
The fundamentals are there, supported by earnings. Let's look at the charts.
5 Products You Didn't Know Were Made By Pfizer
Pfizer is reportedly planning to sell its consumer healthcare business in an auction next month
Cramer: How to Find the Open Receiver in a Pullback
You've got to run the stock checkdown.
Cramer: What's Tax Reform Got to Do With It?
Treasury secretary says it's baked into the market, but is anyone really counting on it?
Dow Powers to New Record, Nears 23,000
The Dow, the Nasdaq and the S&P 500 all reached new record highs even though drug stocks were under pressure following comments by President Trump.
Walmart Leads Consumer Staples Sector Higher
Shares of Walmart jumped higher on Tuesday after the world's largest retailer updated fiscal 2019 forecasts and announced a new share buyback program.
Investors Are Scooping Up Shares of Apple, Ditching Bristol Myers and Pfizer
Investors rolled into shares of Apple in September, according to TD Ameritrade, but took profits on shares of Bristol-Myers and Pfizer shares.
Teva Still Hurts From Self-Inflicted Wounds
It will take time to turn the drugmaker around under new leadership and it likely is dead money for now.
Teva Still Hurts From Self-Inflicted Wounds
It will take time to turn the drugmaker around under new leadership and it likely is dead money for now.
Midday Report: Stocks Mixed Ahead of Federal Reserve Decision
Stocks traded mixed Wednesday.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
Dow Hits Intraday Record but Inflation Numbers Cause Jitters Elsewhere
The Dow Jones Industrial Average hit a fresh intraday record earlier, but the rest of markets remained shaky after the latest inflation numbers called the Fed's plans into question.
Novice Trade: Pfizer
Use limit orders on this one.
Novice Trade: Pfizer
The technical picture has just turned bullish.
Is the Dow That Big a Deal?
The blue-chip index gets all the attention, but doesn't necessarily deserve it.
Jim Cramer on Dow 22,000, Under Armour, Foot Locker, Pfizer and Micron
Jim Cramer weighs in on Tuesday's trending stocks.
Jim Cramer: I'm Confused With Pfizer
They haven't distinguished themselves.
Wall Street Preview: Sprint, Snap and Pfizer in Focus
U.S. stock futures were pointing to strong gains for Wall Street on Tuesday
Stocks Look to Keep Rally Going, Dow Industrials Close to Milestone
The Dow Jones Industrial Average is looking at a strong open and possibly could cross the 22,000 milestone today.
Oil and Earnings. It's TheStreet's Daily Market Preview
Oil major swings to profit as crude prices recover
Novice Trade: Pfizer
If you like pharma, now is the time to scale into the sector.
